Synthesis: Commercial reagents were used as received unless otherwise noted. 4,5-Dimethoxy-2-nitrobenzyl bromide, N,N-Diidopropylethylamine was purchased from Aldrich. NMR spectra were acquired on a Bruker® DRX-500 instrument using deuterated solvents as detailed and at ambient probe temperature (300 K). Notation for the 1 H NMR spectral splitting patterns includes: singlet (s), doublet (d), triplet (t), broad (br) and multiplet/overlapping peaks (m). Signals are quoted as δ values in ppm, coupling constants (J), are quoted in Hertz and approximated to the nearest 0.5. Data analysis for the nuclear magnetic resonance (NMR) spectra was performed using MestReNova® software. Mass spectra were recorded on a Micromass® Q-Tof (ESI) spectrometer. High performance liquid chromatography (HPLC) purification was carried out by using a Varian Pursuit C18, 5 µ column (250 × 21.2 mm) and a gradient elution with H2O/ acetonitrile (MeCN) containing 0.1% TFA at a flow rate of 12.0 ml/ min. Tandem HPLC-MS analysis was performed on a Bruker amaZon X Ion Trap MS and chromatographed by a Dionex UltiMate 3000 UHPLC system equipped with a diode array detector and a column oven. HPLC analyses were performed on a Kinetex C18 column (Phenomenex, 50 × 2.1 mm, 2.6 µm) using the following solvent system: solvent A, 0.1 % Formic acid in water; solvent B, CH 3 CN; flow rate of 1 mL.min -1 ; using the following gradient (0 min: 2% of B à 1.5 min: 5% of B à 2.5 min: 95% of B à 3.5 min: 95 of B). The column temperature was maintained at 30 °C.
In vitro photo-deprotection of [C] -PDS: 500 µL of a 100 µM solution of [C] -PDS in a 10 mM PBS buffer pH 7.0 supplemented with 70 mM KCl, in a quartz cell (l = 1 cm). The cell was then placed 3 cm from the UV lamp (Spectroline ENF-280C/FE, AC 230V, 8W, long wave UV-365nm). The sample was irradiated through the cell while the solution was stirred.
FRET-melting studies: 100 µM stock solutions of oligonucleotides were prepared in molecular biology grade DNase-free water. Further dilutions were carried out in 60 mM potassium cacodylate buffer, pH 7.4. FRET experiments were carried out with a 200 nM oligonucleotide concentration. All labeled DNA oligonucleotides were supplied by Eurogentec® Ltd. Three dual fluorescently labeled DNA oligonucleotides were used in these experiments: SRC (5'-FAM-GGG CGG CGG GCT GGG CGG GG-TAMRA-3'), H-Telo (5′-FAM-GGG TTA GGG TTA GGG TTA GGG-TAMRA-3′), C-myc (5′-FAM-TGA GGG TGG GTA GGG TGG GTA A-TAMRA-3′). The donor fluorophore was 6-carboxyfluorescein (FAM) and the acceptor fluorophore was 6-carboxytetramethylrhodamine (TAMRA). The dual-labeled oligonucleotides were annealed at a concentration of 400 nM by heating at 95 °C for 10 min followed by slow cooling to RT. 96-well plates were prepared by addition of 50 µl of the annealed DNA solution to each well, followed by 50 µl solution of [C] -PDS. Measurements were made in triplicate with an excitation wavelength of 483 nm and a detection wavelength of 533 nm.
Cell culture: MRC5-SV40 cells were cultured in T-75 flasks in Phenol Red free Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal calf serum and split at 70-80% confluency using trypsin EDTA. The MRC5-SV40 cells were a gift from the laboratory of Prof Steve Jackson.
Luminescent cell viability assay: IG50 values of growth inhibition were determined using the cell viability assay CellTiter-GloTM (Promega®). Cells were plated in 96 well plates at a density of 5000 cells per well in 100 µL of media and incubated for 24 h. Compounds were added in serial dilutions (in a range between 0-40 µM) at a volume of 100 µl per well at the respective concentrations. The plates were then placed 3 cm apart from the UV lamp (Spectroline ENF-280C/FE, AC 230V, 8W, long wave UV-365nm) and irradiated for the indicated times. Cell viability was measured after 72 h using the manufacturer's protocol. All measurements were made in triplicate.
Gene expression / mRNA analysis: MRC5-SV40 cells were plated in 96 well plates at a density of 10 000 cells per well in 100 µL of media. The cells were either treated or untreated with 2 µM [C] -PDS. Total RNA was purified from each sample using an RNeasy kit from Qiagen following the manufacturer's protocol. cDNA synthesis of 1 µg of total RNA was performed with the Thermo Scientific Maxima Reverse Transcriptase kit using oligo(dT) primers following the manufacturer's protocol for GC-rich RNA. For quantitative Real-Time PCR (qRT-PCR) analyses, 1/30th of each reaction was used. The following gene specific Quantitect primer assays (Qiagen, cat. number included) were used in our analysis: B2M (QT00088935), ALAS1 (QT0073122), MYC (QT00035406), NOTCH1 (QT01005109), RET (QT00047985), SRC (QT00039326). RT-PCR analysis was performed using Power SYBR ® green (Applied Biosystems) for detection with an CFX96
TM Real-Time system (BioRad). All measurements were made in technical and biological triplicate.Synthesis and characterisation of [C] PDS (20 mg, 33.6 µmol) was mixed in DMF (5 mL) with 1 eq 4,5-Dimethoxy-2-nitrobenzyl bromide (5.88 mg). TEA (100 µL, 260 mmol) was added and the mixture was stirred at RT overnight. The major compound was then purified by HPLC (Gradient: 10 % ACN in H 2 O containing 0.1 % TFA to 90 % ACN over 20 min) to recover [C] -PDS as a white powder (22.7 mg, 28.6 µmol, 85.1 %) after the solvents have been freeze-dried. 168.9, 164.3, 164.2, 163.9, 163.1, 162.8, 155.4, 153.0, 152.9, 151.6, 147.9, 142.9, 132.4, 127.6, 126.5, 123.4, 121.8, 120.6, 116.5, 113.5, 109.8, 95.9, 66.6, 65.4, 57.2, 56.9, 50.7, 48.2, 39.9, 39.8 
